 |
Targeting cancer at its root developing novel drugs that attack Cancer Stem Cells |
| Home | The Company | Pipeline | Cancer Stem Cells | Platform | News & Events | Organization | Collaborations | Contact Us |
| StemScreen® 2 is a proprietary
high throughput screen currently in development. StemScreen® 2
takes advantage of a landmark discovery that cancer cell lines
harbor CSCs. Stemline has exclusively licensed the technology derived
from this discovery from the University of Cambridge which enables
the development of high throughput screens for compounds that target CSCs. |
 |
   |
|